CARLSBAD, Calif., Dec 02, 2010 (BUSINESS WIRE) --
LifeTechnologies Corporation (NASDAQ: LIFE) today announced that its Applied Biosystems Attune(TM) Acoustic Focusing Cytometer has been named one of the Top Ten Innovations of 2010 by The Scientist Magazine. On an annual basis for the past three years, the publication gathers a panel of expert judges to evaluate life science technologies and determine the ten most exciting tools to hit the life sciences market. Attune is a first of its kind cytometry system designed to use sound waves to precisely control the movement of cells.
The groundbreaking, proprietary technology enables scientists to gather statistical data on a large number of heterogeneous cells to study parameters within a cell population, including size, complexity, phenotype and health. By using Attune, scientists can more easily interpret their data due to less variability, save time by increasing throughput, and analyze rare populations faster and more accurately.
"We're proud to be recognized and awarded for technology that we believe will fundamentally change the price/performance curve and make high sensitivity and high throughput flow cytometry easily accessible to most researchers," said Nicolas Barthelemy, President of Cell Systems at Life Technologies. "The acoustic nature of Attune represents the biggest change in the flow cytometry industry in thirty years."
Flow cytometry allows scientists to count and examine cells by passing them through a laser-based detection device. Thousands of cells per second may be counted, allowing rapid characterization of entire populations of cells. Cellular biologists engage in flow cytometry for a rapidly growing range of applications, including the study of proteins expressed by cells (immunophenotyping), quantifying the amount of DNA in cells, cell counting, among others.
The commercialization of Attune leverages the company's expertise in instrumentation, as well as its position as a long-time leading provider of flow cytometry reagents, to create a system that will offer scientists enhanced sample throughput, sensitivity and accuracy for a range of cell biology applications.
In 2007, Life Technologies was also honored with this award for its next-generation genomic analysis SOLiD(TM) System.
For Research Use Only. Not for use in diagnostic procedures.
About Life Technologies (www.lifetechnologies.com)
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology tools company dedicated to improving the human condition. Our systems, consumables and services enable researchers to accelerate scientific exploration, driving to discoveries and developments that make life even better. Life Technologies customers do their work across the biological spectrum, working to advance personalized medicine, regenerative science, molecular diagnostics, agricultural and environmental research, and 21st century forensics. Life Technologies had sales of $3.3 billion in 2009, employs approximately 9,000 people, has a presence in approximately 160 countries, and possesses a rapidly growing intellectual property estate of approximately 3,900 patents and exclusive licenses. Life Technologies was created by the combination of Invitrogen Corporation and Applied Biosystems Inc., and manufactures both in-vitro diagnostic products and research use only-labeled products. For more information on how we are making a difference, please visit our website: http://www.lifetechnologies.com.
Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
SOURCE: Life Technologies Corporation
Life Technologies Corporation
Lauren Lum
650-638-6916
lauren.lum@lifetech.com
